Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome: genes and variants
Explore variant evidence for Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome across 1 analyzed protein (PIEZO2). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 18 variants of uncertain significance and 3 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
PIEZO2: Piezo-type mechanosensitive ion channel component 2
It converts mechanical force into electrical signals by opening a cation channel, enabling light-touch sensation and awareness of body position and movement. Activating variants can cause distal arthrogryposis syndromes with congenital joint contractures, while biallelic loss of function impairs proprioception and discriminative touch.
9 ClinVar pathogenic / likely pathogenic and 21 uncertain variants in PIEZO2 have source records linked to Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PIEZO2 R2686G | 2686 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PIEZO2 M712V | 712 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PIEZO2 I791K | 791 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PIEZO2 R2718L | 2718 | Cytoplasmic | Pathogenic / likely pathogenic |
| PIEZO2 S2739P | 2739 | Cytoplasmic | Pathogenic / likely pathogenic |
| PIEZO2 M998T | 998 | Transmembrane | Pathogenic / likely pathogenic |
| PIEZO2 T2221I | 2221 | Extracellular | Pathogenic / likely pathogenic |
| PIEZO2 S2223L | 2223 | Extracellular | Pathogenic / likely pathogenic |
| PIEZO2 I802F | 802 | Transmembrane | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| PIEZO2 R2718P | 2718 | Cytoplasmic | Uncertain (★) | +6: R2718L at the same position is pathogenic; REVEL 0.987 |
Which prediction tools work for Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 99 out of 100
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 98 out of 100
- VARITY: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 97 out of 100
- SIFT: 95 out of 100
- CADD: 93 out of 100
- MetaSVM: 84 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 82 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Arthrogryposis, distal, with impaired proprioception and touch also has ClinVar records linked to PIEZO2 variants; they fall mostly in different places as the Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome variants (3 pathogenic / likely pathogenic).
Diseases related to Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
- Gordon syndrome, also linked to PIEZO2
- Arthrogryposis, distal, with impaired proprioception and touch, also linked to PIEZO2
- Marden-Walker syndrome, also linked to PIEZO2
Frequently asked questions
Which genes have records linked to Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome?
This view contains 1 analyzed proteins: PIEZO2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 18 variants of uncertain significance and 3 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 38 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center